Skip to Content

Methyltestosterone Pregnancy and Breastfeeding Warnings

Methyltestosterone is also known as: Android, Android-10, Android-25, Methitest, Oreton Methyl, Testred, Virilon

Medically reviewed on February 13, 2018.

Methyltestosterone Pregnancy Warnings

Methyltestosterone has been assigned to pregnancy category X by the FDA. Androgen use, particularly during the first trimester of pregnancy, causes virilization of the external genitalia of the female fetus. Reversible oligospermia may occur after prolonged androgen administration or excessive dosage. There are no controlled data in human pregnancy. Methyltestosterone use is considered contraindicated during pregnancy.

If reversible oligospermia occurs, the androgen can be discontinued and if restarted, a lower dosage should be utilized.

See references

Methyltestosterone Breastfeeding Warnings

There are no data on the excretion of methyltestosterone into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Android Capsules (methyltestosterone)." ICN Pharmaceuticals Inc, Costa Mesa, CA.

References for breastfeeding information

  1. "Product Information. Android Capsules (methyltestosterone)." ICN Pharmaceuticals Inc, Costa Mesa, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide